Bone scintigraphy in prostate cancer. Correlation with clinical and laboratory features and with survival;Cintigrafía ósea en pacientes con cáncer de próstata: Correlación con aspectos clínicos, de laboratorio y sobrevida

Revista Medica de Chile

Volumn 127, Issue 2, 1999, Pages 181-188

  Lobo S , Gabriel ^a   De Guevara Hernández, David Ladrón ^a,b   Salgado B , Gustavo ^a   Donoso R , Gilda ^a   Bagus A , Franz ^a  

^a HOSPITAL SAN JUAN DE DIOS   (Chile)

^b NONE   (Chile)

Author keywords

Prostatic diseases; Prostatic neoplasms; Prostatic specific y antigen; Radionuclide imaging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BONE; BONE TUMOR; DISEASE FREE SURVIVAL; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROSTATE TUMOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BONE AND BONES; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0033073483     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. HARBERT J. The Musculoskeletal Sistem. En: Harbert J, Eckelman W, Neumann R, ed. Nuclear Medicine: Diagnosis and Therapy. New York: Thieme Medical Publishers, Inc, 1996; 801-64.
2. GREENSPAN A, STADALNIK R. A Musculoskeletal Radiologist's View of Nuclear Medicine. Sem Nucl Med 1997; 27: 372-85.
3. KRASNOW A, HELLMAN R, TIMINS M, COLLIER D, ANDERSON T, ISITMAN A. Diagnostic Bone Scanning in Oncology. Sem Nucl Med 1997; 27: 107-41.
4. MAEDA H, KOIZUMI M, YOSHIMURA K, YAMAUCHI T, KAWAI T, OGATA E. Correlation between Bone Metabolic Markers and Bone Scan in Prostatic Cancer. J Urol 1997; 157: 539-43.
5. SOLOWAY M, HARDEMAN S, HICKEY D, RAYMOND J, TODD B, SOLOWAY S ET AL. Stratification of Patients with Metastatic Prostate Cancer Based on Extent of Disease on Initial Bone Scan. Cancer 1988; 61: 195-202.
6. EARLY P. Bone. Imaging Studies. En: Early P, Sodee B, ed. Principles and Practice of Nuclear Medicine. St Louis, Missouri: Mosby-Year Book; Inc 1995; 339-69.
7. RUDONI M, ANTONINI G, FAVRO M, BAROLI A, BRAMBILLA M, CARDANI G ET AL. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer. Eur J Nucl Med 1995; 22: 207-11.
8. HAUKAAS S, ROERVIK J, HALVORSEN OJ, FUELLING M. When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? Br J Urol 1997; 79: 770-6.
9. MOROTE J, LORENTE JA, ENCABO G. Prostate Carcinoma Staging: Clinical Utility of Bone Alkaline Phosphatase in Addition to Prostate Specific Antigen. Cancer 1996; 78: 2374-8.
10. SMITH PH, BONO A, CALAIS DA SILVA F, DEBRUYNE F, DENIS L, ROBINSON P ET AL. Some Limitations of the Radioisotope Bone Scan in Patients With Metastatic Prostatic Cancer. Cancer 1990; 66: 1009-16.
11. KNUDSON G, GRINIS G, LÓPEZ-MAJANO V, SANSI P, TARGONSKI P, RUBENSTEIN M ET AL. Bone Scan as a Stratification Variable in Advanced Prostate Cancer. Cancer 1991; 68: 316-20.
12. LEE CT, OESTERLING JE. Using Prostate-Specific Antigen to Eliminate the Staging Radionuclide Bone Scan. Urol Clin North Am 1997; 24: 389-94.
13. O'MARA R, WEBER D. The Osseous System. En: Freeman LM, ed. Freeman and Johnson's Clinical Radionuclide Imaging. Third ed. Orlando: Grune and Stratton; 1984; 1141-239.
14. RATTIER C, ROSSI D, COULANGE C, RAMPAL M, SERMENT G. Stage M1b prostatic adenocarcinoma: prognostic factors, value of bone scintigraphy. Prog Urol 1994; 4: 984-99.
15. SANDHU DP, MAYOR P, SAMBROOK PA, GEORGE NJ. Outcome and prognostic factors in patients with advanced prostate cancer and abstructive uropathy. Br J Urol 1992; 70: 412-6.
16. JORGENSEN T, MÜLLER C, KAALHUS O, DANIELSEN HE, TVETER KJ. Extent of disease based on initial bone scan: important prognostic predictor for patients with metastasic prostatic cancer. Eur Urol 1995; 28: 40-6.
17. YAMASHITA K, DENNO K, UEDA T, KOMATSUBARA Y, KOTAKE T, USAMI M ET AL. Prognostic significance of bone metastases in patients with metastasic prostate cancer. Cancer 1993; 71: 1297-302.
18. CHYBOVPSKI FM, KELLER JJ, BERGSTRALH EJ, OESTERLING JE. Predicting radionuclide bone scan findings in patients with newly diagnosed, untrated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 1992; 147: 474.